Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mediwelcome Healthcare Management & Technology Inc. ( (HK:2159) ) has shared an update.
Mediwelcome Healthcare Management & Technology Inc. has agreed to acquire 100% of Mediai Technology Development Limited for HK$139.77 million, to be settled in cash and a promissory note, marking a major transaction under Hong Kong listing rules. The deal is intended to strengthen the group’s healthcare technology capabilities and broaden its operational scope.
To fund the acquisition, the company plans to place up to 65 million new shares at HK$1.86 each, potentially raising about HK$115.13 million in net proceeds, subject to shareholder approval. Any excess funds after paying the cash portion of the consideration may support the group’s AI medical vertical model development business or be used to repay the promissory note, which could reinforce its strategic pivot toward AI-enabled healthcare solutions while diluting existing shareholders’ stakes.
The most recent analyst rating on (HK:2159) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on Mediwelcome Healthcare Management & Technology Inc. stock, see the HK:2159 Stock Forecast page.
More about Mediwelcome Healthcare Management & Technology Inc.
Mediwelcome Healthcare Management & Technology Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the healthcare management and technology sector. The company focuses on medical services and technology solutions, and is expanding into innovative AI-driven medical vertical models to enhance its product and service offerings in the healthcare market.
Average Trading Volume: 567,543
Technical Sentiment Signal: Buy
Current Market Cap: HK$585.2M
Learn more about 2159 stock on TipRanks’ Stock Analysis page.